Streamex Joins Project Open to Drive Digital Asset Tokenization
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 10 2025
0mins
Source: Newsfilter
- Project Collaboration: Streamex Corp. announces its participation in Project Open, aimed at establishing a compliant blockchain framework for securities issuance and trading, which is expected to unlock billions in traditional asset value and drive financial innovation.
- Market Efficiency Enhancement: Through Project Open, Streamex's GLDY tokenized security will enable 24/7 trading and instant settlement, reducing transaction costs and improving transparency, thereby enhancing investor confidence.
- Compliance and Accessibility: The initiative will provide institutional investors with compliant trading pathways for tokenized assets, significantly broadening the universe of eligible investors and accelerating institutional adoption of RWAs.
- Strategic Implications: Streamex's involvement represents not just an opportunity to expand GLDY's trading capabilities but also a foundational step toward transitioning traditional markets to blockchain, helping the company maintain a competitive edge in the fast-evolving financial landscape.
Analyst Views on STEX
Wall Street analysts forecast STEX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STEX is 12.00 USD with a low forecast of 12.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.120
Low
12.00
Averages
12.00
High
12.00
Current: 3.120
Low
12.00
Averages
12.00
High
12.00
About STEX
Streamex Corp., formerly BioSig Technologies, Inc., is a real world asset (RWA) tokenization company. The Company with institutional grade infrastructure brings the gold and commodities market on chain, enabled by a gold denominated treasury and tokenization technology powering the modern commodities market. The Company is a wholly owned subsidiary of BioSig Technologies, Inc.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





